Markt für Endometriumablationsgeräte in Nordamerika und Europa – Branchentrends und Prognose bis 2030

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Markt für Endometriumablationsgeräte in Nordamerika und Europa – Branchentrends und Prognose bis 2030

  • Medical Devices
  • Publish Reports
  • Oct 2023
  • Country Level
  • 350 Seiten
  • Anzahl der Tabellen: 528
  • Anzahl der Abbildungen: 39

North America And Europe Endometrial Ablation Devices Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2030
Diagramm Marktgröße (Basisjahr)
USD 267,354.00 Thousand
Diagramm Marktgröße (Prognosejahr)
USD 471,904.07 Thousand
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>Markt für Endometriumablationsgeräte in Nordamerika und Europa, nach Produkttyp (System/Ausrüstung, Verbrauchsmaterialien und andere), Tragbarkeit (tragbar, Standalone und Tischgerät), Standort (Einrichtungsbasierter Verfahrensstandort und In-Office-Verfahrensstandort), Technologie (Radiofrequenzablation, Hydrothermale Ablation, Thermische Ballonablation, Kryoablation, Mikrowellenablation, Laserablation und andere), Technik (Nicht-Resektoskopisch und Resektoskopisch), Anwendung (Abnorme Uterusblutung (AUB), Menorrhagie (Starke Menstruationsblutung), Dysmenorrhoe (Schmerzhafte Menstruation), Polypen, Myome, Adenomyose und andere), Altersgruppe (Perimenopausal, Prämenopausal und Postmenopausal), Endbenutzer (Krankenhäuser, Ambulante Chirurgische Zentren, Unabhängige Behandlungszentren, Diagnostische Bildgebungszentren, Klinische Laboratorien, Katheterisierungslaboratorien und Sonstiges), Vertriebskanäle (Direktausschreibung, Einzelhandelsverkauf und Sonstiges) – Branchentrends und Prognose bis 2030.

Marktanalyse und Einblicke für Endometriumablationsgeräte in Nordamerika und Europa

Der Markt für Endometriumablationsgeräte in Nordamerika und Europa stellt zwei der bedeutendsten Regionen der globalen Gesundheitsbranche dar. Diese Märkte haben in den letzten Jahren aufgrund mehrerer Faktoren ein erhebliches Wachstum und eine erhebliche Entwicklung erlebt. In Nordamerika, zu dem die USA und Kanada gehören, profitierte der Markt von einer gut etablierten Gesundheitsinfrastruktur, einer hohen Prävalenz gynäkologischer Erkrankungen wie Menorrhagie und Myomen sowie einem wachsenden Bewusstsein bei Patienten und Gesundheitsdienstleistern für minimalinvasive Behandlungsmöglichkeiten. Die Einführung fortschrittlicher medizinischer Technologien und die Präsenz wichtiger Akteure der Branche haben das Marktwachstum weiter angekurbelt. Darüber hinaus haben staatliche Initiativen und Versicherungsschutz für solche Verfahren den Patienten den Zugang zu Endometriumablationsbehandlungen erleichtert und zur allgemeinen Marktexpansion beigetragen.

Markt für Endometriumablationsgeräte in Nordamerika und EuropaMarkt für Endometriumablationsgeräte in Nordamerika und Europa

Der nordamerikanische und europäische Markt für Geräte zur Endometriumablation wird im Prognosezeitraum 2023 bis 2030 voraussichtlich ein Marktwachstum verzeichnen. Data Bridge Market Research analysiert, dass der Markt im Prognosezeitraum 2023 bis 2030 mit einer CAGR von 7,6 % wächst und in Nordamerika von 267.354.000 USD im Jahr 2022 auf 471.904.070 USD im Jahr 2030 ansteigen soll. Data Bridge Market Research analysiert, dass der Markt im Prognosezeitraum 2023 bis 2030 mit einer CAGR von 7,3 % wächst und in Europa von 186.661.810 USD im Jahr 2022 auf 320.682.850 USD im Jahr 2030 ansteigen soll.

Der Marktbericht für Endometriumablationsgeräte in Nordamerika und Europa enthält Einzelheiten zu Marktanteilen, neuen Entwicklungen und Produktpipeline-Analysen, den Auswirkungen inländischer und lokaler Marktteilnehmer, analysiert Chancen in Bezug auf neu entstehende Umsatzquellen, Änderungen der Marktvorschriften, Produktzulassungen, strategische Entscheidungen, Produkteinführungen, geografische Expansionen und technologische Innovationen auf dem Markt. Um die Analyse und das Marktszenario zu verstehen, kontaktieren Sie uns für ein Analystenbriefing. Unser Team hilft Ihnen bei der Entwicklung einer umsatzwirksamen Lösung, um Ihr gewünschtes Ziel zu erreichen. Die Skalierbarkeit und Geschäftsausweitung der Einzelhandelseinheiten in den Entwicklungsländern verschiedener Regionen sowie die Partnerschaft mit Lieferanten für den sicheren Vertrieb von Maschinen- und Arzneimittelprodukten sind die Haupttreiber, die die Nachfrage des Marktes im Prognosezeitraum angetrieben haben.

Berichtsmetrik

Details

Prognosezeitraum

2023 bis 2030

Basisjahr

2022

Historische Jahre

2021 (anpassbar auf 2015–2020)

Quantitative Einheiten

Umsatz in Tausend USD

Abgedeckte Segmente

Produkttyp (System/Ausrüstung, Verbrauchsmaterial und andere), Tragbarkeit (tragbar, Standalone und Tischgerät), Standort (Einrichtungsbasierter Verfahrensstandort und In-Office-Verfahrensstandort), Technologie (Radiofrequenzablation, Hydrothermale Ablation, Thermische Ballonablation, Kryoablation, Mikrowellenablation, Laserablation und andere), Technik (Nicht-Resektoskopisch und Resektoskopisch), Anwendung (Abnorme Uterusblutung (AUB), Menorrhagie (Starke Menstruationsblutung), Dysmenorrhoe (Schmerzhafte Menstruation), Polypen, Myome, Adenomyose und andere), Altersgruppe (Perimenopausal, Prämenopausal und Postmenopausal), Endbenutzer (Krankenhäuser, Ambulante Chirurgische Zentren, Unabhängige Behandlungszentren, Diagnostische Bildgebungszentren, Klinische Laboratorien, Katheterisierungslaboratorien und andere), Vertriebskanal (Direktausschreibung, Einzelhandelsverkauf und Andere)

Abgedeckte Länder

USA, Kanada, Mexiko, Großbritannien, Deutschland, Frankreich, Italien, Spanien, Russland, Türkei, Belgien, Niederlande, Schweiz, Dänemark, Norwegen, Schweden, Finnland, Polen und Rest von Europa   

Abgedeckte Marktteilnehmer

CooperSurgical Inc., Hologic, Inc., Minerva Surgical, Inc., Medtronic, IDOMAN-MED, Veldana Medical, Channel Medsystems Inc., Olympus, Gynesonics, RF Medical Co., Ltd., LiNA Medical ApS., OCON Medical Ltd. und unter anderem        

Marktdefinition für Endometriumablationsgeräte in Nordamerika und Europa

Geräte zur Endometriumablation sind ein Spezialsegment der Medizintechnikbranche, das für eine Reihe gynäkologischer Erkrankungen entwickelt wurde, wobei der Schwerpunkt auf der Behandlung von anormalen Gebärmutterblutungen (Menorrhagie) und anderen damit verbundenen Erkrankungen liegt. Diese Geräte werden bei minimalinvasiven Eingriffen eingesetzt, um die Gebärmutterschleimhaut zu entfernen oder zu zerstören, die eine entscheidende Rolle bei der Regulierung des Menstruationszyklus spielt. Auf diese Weise lindern sie übermäßige Menstruationsblutungen und die damit verbundenen Symptome und bieten eine Alternative zu invasiveren chirurgischen Eingriffen wie der Hysterektomie. Der Markt für Geräte zur Endometriumablation umfasst eine Vielzahl von Technologien, darunter Radiofrequenzablation, Kryoablation, Mikrowellenablation und thermische Ballonablation. Diese Geräte werden in klinischen Umgebungen, oft ambulant, eingesetzt und haben aufgrund ihrer Wirksamkeit, verkürzten Genesungszeiten und des geringeren Komplikationsrisikos im Vergleich zu herkömmlichen chirurgischen Eingriffen an Popularität gewonnen.

Marktdynamik für Endometriumablationsgeräte in Nordamerika und Europa

Treiber

  • Zunehmende Häufigkeit von Menstruationsbeschwerden

Menstruationsstörungen umfassen eine Reihe von Erkrankungen, die den normalen Menstruationszyklus bei Frauen beeinträchtigen. Diese Störungen können sich als unregelmäßige, starke, schmerzhafte oder ausbleibende Menstruationsblutungen äußern und sind häufig auf hormonelle Ungleichgewichte, strukturelle Anomalien der Fortpflanzungsorgane, Erkrankungen wie das polyzystische Ovarialsyndrom (PCOS) oder bestimmte Medikamente zurückzuführen. Häufige Menstruationsstörungen sind Menorrhagie (übermäßige Menstruationsblutung), Oligomenorrhoe (seltene Perioden), Dysmenorrhoe (schmerzhafte Menstruation) und Amenorrhoe (Ausbleiben der Menstruation). Menstruationsstörungen können das körperliche und emotionale Wohlbefinden, die Fruchtbarkeit und die allgemeine Lebensqualität einer Frau erheblich beeinträchtigen und erfordern häufig eine medizinische Untersuchung und Behandlung, um die Symptome zu lindern und die zugrunde liegenden Ursachen zu behandeln.

Da die Zahl der Menstruationsbeschwerden in diesen Regionen weiter zunimmt, gibt es immer mehr Patientinnen, die eine Behandlung für ihre Beschwerden suchen. Viele Frauen mit schweren Menstruationsbeschwerden wie Menorrhagie finden herkömmliche Behandlungen wie Medikamente oder Hormontherapie wirkungslos. Die Endometriumablation bietet eine alternative und wirksame Lösung, was die Nachfrage nach Ablationsgeräten erhöht.

Daher ist zu erwarten, dass die zunehmende Häufigkeit gynäkologischer Erkrankungen ein Wachstumstreiber für den Markt für Geräte zur Endometriumablation in Nordamerika und Europa sein wird.

Zurückhaltung

  • Strenge regulatorische Anforderungen für Ablationsgeräte

Strenge gesetzliche Vorschriften für Ablationsgeräte in Nordamerika sind unerlässlich, um die Gesundheit der Patienten zu schützen und die Wirksamkeit und Sicherheit der in verschiedenen klinischen Verfahren eingesetzten medizinischen Geräte sicherzustellen. Diese Vorschriften sollen die mit diesen Geräten verbundenen Risiken minimieren und ihre Qualität und Leistung sicherstellen.

In Nordamerika spielt die US-amerikanische Food and Drug Administration (FDA) eine zentrale Rolle bei der Regulierung medizinischer Geräte, darunter auch Ablationsgeräte. Die FDA klassifiziert diese Geräte anhand ihres Risikoniveaus, wobei Geräte mit höherem Risiko in der Regel strengere Zulassungsverfahren erfordern. Geräte der Klasse II oder III benötigen häufig eine Zulassung oder Genehmigung vor der Markteinführung. Das 510(k)-Verfahren wird häufig für Ablationsgeräte verwendet, bei dem Hersteller eine wesentliche Gleichwertigkeit mit bereits legal vermarkteten Geräten nachweisen müssen. Für Geräte mit höherem Risiko ist eine Zulassung vor der Markteinführung (PMA) erforderlich, die umfangreiche klinische Daten und ein umfassenderes Prüfverfahren umfasst.

Markt für Endometriumablationsgeräte in Nordamerika und Europa

Gelegenheit

  • Wachsende Präferenz für minimalinvasive Verfahren

Die zunehmende Präferenz für minimalinvasive Verfahren stellt einen bedeutenden Trend im Gesundheitswesen dar, der von mehreren Faktoren getrieben wird, bei denen der Komfort des Patienten, eine schnellere Genesung und weniger Komplikationen im Vordergrund stehen.

Minimalinvasive Verfahren erfreuen sich aus folgenden Gründen zunehmender Beliebtheit:

  • Reduziertes Trauma und Narbenbildung: Minimalinvasive Verfahren zeichnen sich durch kleinere oder gar keine Einschnitte aus, was weniger körperliches Trauma für den Körper bedeutet. Dies führt zu minimaler Narbenbildung und weniger postoperativen Schmerzen im Vergleich zu herkömmlichen offenen Operationen, was sie für Patienten attraktiver macht.
  • Schnellere Genesungszeiten: Minimalinvasive Eingriffe erfordern häufig kürzere Krankenhausaufenthalte oder ambulante Behandlungen, sodass die Patienten früher zu ihren täglichen Aktivitäten zurückkehren können. Diese schnelle Genesung ist besonders für Personen mit einem geschäftigen Leben und Verpflichtungen attraktiv.

Daher ist zu erwarten, dass die zunehmende Präferenz für minimalinvasive Verfahren eine Chance für den nordamerikanischen und europäischen Markt für Geräte zur Endometriumablation darstellt.

Herausforderung

  • Mit der Endometriumablation verbundene Risiken

Die Endometriumablation gilt allgemein als sicheres und wirksames Verfahren zur Behandlung starker Menstruationsblutungen und bestimmter Endometriumerkrankungen. Wie bei jedem medizinischen Verfahren sind jedoch auch hier gewisse Risiken und mögliche Komplikationen verbunden.

Mit der Endometriumablation sind folgende Risiken verbunden:

  • Die gewünschten Ergebnisse werden nicht erzielt: Eine Endometriumablation kann starke Menstruationsblutungen oder andere Endometriumerkrankungen nicht immer vollständig beheben. In einigen Fällen kann der Eingriff weniger wirksam sein als erwartet, was zu anhaltenden oder wiederkehrenden Symptomen führt.
  • Infektion: Obwohl selten, besteht nach einer Endometriumablation das Risiko einer Infektion. Infektionen können in der Gebärmutter oder am Eintrittspunkt des Ablationsgeräts auftreten. Anzeichen einer Infektion können Fieber, Bauchschmerzen und abnormaler Vaginalausfluss sein.

Daher ist davon auszugehen, dass die mit der Endometriumablation verbundenen Risiken eine Herausforderung für den nordamerikanischen und europäischen Markt für Endometriumablationsgeräte darstellen werden.

Jüngste Entwicklungen

  • Im November 2021 stellt Hologic, Inc., ein weltweit führendes Unternehmen in der Frauengesundheit, auf dem 50. Weltkongress der American Association of Gynecologic Laparoscopy (AAGL) das NovaSure V5-Gerät vor, ein globales Gerät zur Endometriumablation (GEA). Das innovative neue NovaSure V5-Gerät ist die am besten erforschte und vertrauenswürdigste Methode zur Endometriumablation in den Vereinigten Staaten und steht für Hologics anhaltendes Engagement zur Verbesserung der Erfahrung der Ärzte. 
  • Im Februar 2021 gab CooperSurgical Inc. die Übernahme des in Kalifornien ansässigen Unternehmens AEGEA Medical und seines von der FDA zugelassenen Mara-Wasserdampfablationssystems bekannt. Die Übernahme baut auf mehr als 30 Jahren Erfahrung in der Frauengesundheit auf und ergänzt CooperSurgicals wachsendes Portfolio an medizinischen Produkten mit Schwerpunkt auf klinischer und praktischer Frauengesundheit.    

Marktumfang für Endometriumablationsgeräte in Nordamerika und Europa

Der Markt für Endometriumablationsgeräte in Nordamerika und Europa ist in neun wichtige Segmente unterteilt, basierend auf Produkttyp, Tragbarkeit, Standort, Technologie, Technik, Anwendung, Altersgruppe, Endbenutzer und Vertriebskanal. Das Wachstum zwischen den Segmenten hilft Ihnen bei der Analyse von Nischenwachstumsbereichen und Strategien zur Marktbearbeitung und zur Bestimmung Ihrer Hauptanwendungsbereiche und der Unterschiede in Ihren Zielmärkten.   

Produkttyp

  • System/Ausrüstung
  • Verbrauchsmaterial
  • Sonstiges 

Auf der Grundlage des Produkttyps ist der Markt in Systeme/Geräte, Verbrauchsmaterialien und Sonstiges segmentiert.

Portabilität

  • Tragbar
  • Standalone
  • Tischgerät

Auf der Grundlage der Portabilität ist der Markt in tragbare, eigenständige und Tischgeräte segmentiert.

Website

  • Einrichtungsbasierter Verfahrensstandort
  • In-Office-Verfahrenssite

Auf Grundlage des Standorts ist der Markt in einrichtungsbasierte Verfahrensorte und bürobasierte Verfahrensorte segmentiert.

Technologie

  • Radiofrequenzablation
  • Hydrothermale Ablation
  • Thermische Ballonablation
  • Kryoablation
  • Mikrowellenablation
  • Laserablation
  • Sonstiges 

Auf der Grundlage der Technologie ist der Markt in Radiofrequenzablation, hydrothermale Ablation, thermische Ballonablation, Kryoablation, Mikrowellenablation, Laserablation und andere unterteilt.

Technik

  • Nicht-resektoskopisch
  • Resektoskopisch

Auf der Grundlage der Technik ist der Markt in nicht-resektoskopische und resektoskopische Segmente unterteilt.

Anwendung

  • Abnorme Gebärmutterblutung (AUB)
  • Menorrhagie (starke Menstruationsblutung)
  • Dysmenorrhoe (schmerzhafte Menstruation)
  • Polypen
  • Myome
  • Adenomyose
  • Sonstiges

Auf der Grundlage der Anwendung ist der Markt in abnorme Gebärmutterblutungen (AUB), Menorrhagie (starke Menstruationsblutung), Dysmenorrhoe (schmerzhafte Menstruation), Polypen, Myome, Adenomyose und andere unterteilt.

Altersgruppe

  • Perimenopause
  • Prämenopausal
  • Postmenopausal

Auf der Grundlage der Altersgruppe ist der Markt in Perimenopause, Prämenopause und Postmenopause segmentiert.

Endbenutzer

  • Krankenhäuser
  • Ambulante Chirurgische Zentren
  • Unabhängige Behandlungszentren
  • Zentren für diagnostische Bildgebung
  • Klinische Labore
  • Katheterisierungslabore
  • Sonstiges

Auf der Grundlage des Endbenutzers ist der Markt in Krankenhäuser, ambulante chirurgische Zentren, unabhängige Behandlungszentren, Zentren für diagnostische Bildgebung, klinische Labore, Katheterlabore und andere unterteilt. 

Vertriebskanal

  • Direkte Ausschreibung
  • Einzelhandelsumsätze
  • Sonstiges

Auf der Grundlage des Vertriebskanals ist der Markt in Direktausschreibungen, Einzelhandelsverkäufe und andere segmentiert.

 Markt für Endometriumablationsgeräte in Nordamerika und Europa

Nordamerika & Europa Endometriumablation Geräte Markt Regionale Analyse/Einblicke

Der nordamerikanische und europäische Markt für Geräte zur Endometriumablation ist basierend auf Produkttyp, Tragbarkeit, Standort, Technologie, Technik, Anwendung, Altersgruppe, Endbenutzer und Vertriebskanal in neun wichtige Segmente unterteilt.

Die in diesem Marktbericht abgedeckten Länder sind die USA, Kanada, Mexiko, Großbritannien, Deutschland, Frankreich, Italien, Spanien, Russland, Türkei, Belgien, Niederlande, Schweiz, Dänemark, Norwegen, Schweden, Finnland, Polen und der Rest von Europa.    

Aufgrund der Präsenz wichtiger Marktteilnehmer auf diesem größten Verbrauchermarkt mit hohem BIP dürften die USA Nordamerika dominieren. In Europa dürfte Großbritannien dominieren, da die Produktion von intraoralen Dentalscannern zunimmt, die Nachfrage aus den Schwellenmärkten steigt und die Gesundheitsbranche expandiert. 

Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Trends des Marktes auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe, demografische Daten des Landes, Regulierungsgesetze und Import-/Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Prognoseanalyse der Länderdaten werden auch die Präsenz und Verfügbarkeit nordamerikanischer Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen der Vertriebskanäle berücksichtigt.

Wettbewerbsumfeld und Analyse der Marktanteile von Geräten zur Endometriumablation in Nordamerika und Europa

Die Wettbewerbslandschaft des nordamerikanischen und europäischen Marktes für Endometriumablationsgeräte liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -anlagen, Stärken und Schwächen des Unternehmens, Produkteinführung, Produkttestpipelines, Produktzulassungen, Produktbreite und -breite, Anwendungsdominanz, Technologie-Lebenslinienkurve. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus des Unternehmens auf den nordamerikanischen und europäischen Markt für Endometriumablationsgeräte.

Zu den wichtigsten Akteuren auf dem nordamerikanischen und europäischen Markt für Geräte zur Endometriumablation zählen CooperSurgical Inc., Hologic, Inc., Minerva Surgical, Inc., Medtronic, IDOMAN-MED, Veldana Medical, Channel Medsystems Inc., Olympus, Gynesonics, RF Medical Co., Ltd., LiNA Medical ApS., OCON Medical Ltd. und andere.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Inhaltsverzeichnis

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT SEGMENT LIFELINE CURVE IN NORTH AMERICA

2.8 PRODUCT SEGMENT LIFELINE CURVE IN EUROPE

2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.1 DBMR MARKET POSITION GRID

2.11 EUROPE

2.12 MARKET APPLICATION COVERAGE GRID

2.13 VENDOR SHARE ANALYSIS

2.14 SECONDARY SOURCES

2.15 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL'S MODEL

4.2 PORTER'S 5 FORCES

5 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING INCIDENCE OF MENSTRUAL DISORDERS

6.1.2 RISING PREVALENCE OF ENDOMETRIAL CANCER

6.1.3 CHANGING LIFESTYLES AND DELAYED CHILDBEARING

6.2 RESTRAINTS

6.2.1 STRINGENT REGULATORY REQUIREMENTS FOR ABLATION DEVICES

6.2.2 HIGH COST ASSOCIATED WITH ENDOMETRIAL ABLATION PROCEDURE

6.3 OPPORTUNITIES

6.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES

6.3.2 ADVANCEMENTS IN ABLATION TECHNOLOGIES

6.4 CHALLENGES

6.4.1 RISKS ASSOCIATED WITH ENDOMETRIAL ABLATION

6.4.2 AVAILABILITY OF ALTERNATE TREATMENT OPTIONS

7 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 SYSTEM/EQUIPMENT

7.2.1 BY TYPE

7.2.1.1 RADIOFREQUENCY ABLATION DEVICE

7.2.1.1.1 BIPOLAR RADIOFREQUENCY ABLATION DEVICES

7.2.1.1.2 MONOPOLAR RADIOFREQUENCY ABLATION DEVICES

7.2.1.2 HYDROTHERMAL ABLATION DEVICE

7.2.1.3 THERMAL BALLOON ABLATION DEVICE

7.2.1.3.1 HYDROTHERMAL BALLOON ABLATION DEVICES

7.2.1.3.2 GAS-FILLED THERMAL BALLOON ABLATION DEVICES

7.2.1.4 CRYOABLATION DEVICE

7.2.1.4.1 PROBE CRYOABLATION DEVICES

7.2.1.4.2 BALLOON CRYOABLATION DEVICES

7.2.1.5 MICROWAVE ABLATION DEVICE

7.2.1.6 LASER ABLATION DEVICE

7.2.1.7 OTHERS

7.2.2 BY MODALITY

7.2.2.1 PORTABLE

7.2.2.2 STANDALONE

7.2.2.3 BENCHTOP

7.3 CONSUMABLES

7.3.1 ENDOMETRIAL ABLATION PROBES

7.3.1.1 STERILE

7.3.1.2 NON-STERILE

7.3.2 ELECTRODE

7.3.2.1 ABLATION SINGLE ELECTRODE KITS

7.3.2.2 ABLATION MULTIPLE ELECTRODE KITS

7.3.2.3 ABLATION CLUSTER ELECTRODE KITS

7.3.3 ABLATION SYSTEM GROUNDING PAD

7.3.4 CATHETERS

7.3.5 CANNULA

7.3.6 NEEDLES

7.3.7 OTHERS

7.4 OTHERS

8 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY

8.1 OVERVIEW

8.2 PORTABLE

8.3 STANDALONE

8.4 BENCHTOP

9 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE

9.1 OVERVIEW

9.2 FACILITY BASED PROCEDURE SITE

9.3 IN OFFICE PROCEDURE SITE

10 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY

10.1 OVERVIEW

10.2 RADIOFREQUENCY ABLATION

10.3 HYDROTHERMAL ABLATION

10.4 THERMAL BALLOON ABLATION

10.5 CRYOABLATION

10.6 MICROWAVE ABLATION

10.7 LASER ABLATION

10.8 OTHERS

11 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE

11.1 OVERVIEW

11.2 NON-RESECTOSCOPIC

11.2.1 SYSTEM/EQUIPMENT

11.2.2 CONSUMABLES

11.2.3 OTHERS

11.3 RESECTOSCOPIC

11.3.1 SYSTEM/EQUIPMENT

11.3.2 CONSUMABLES

11.3.3 OTHERS

12 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION

12.1 OVERVIEW

12.2 ABNORMAL UTERINE BLEEDING (AUB)

12.2.1 SYSTEM/EQUIPMENT

12.2.2 CONSUMABLES

12.2.3 OTHERS

12.3 MENORRHAGIA (HEAVY MENSTRUAL BLEEDING)

12.3.1 SYSTEM/EQUIPMENT

12.3.2 CONSUMABLES

12.3.3 OTHERS

12.4 DYSMENORRHEA (PAINFUL MENSTRUATION)

12.4.1 SYSTEM/EQUIPMENT

12.4.2 CONSUMABLES

12.4.3 OTHERS

12.5 POLYPS

12.5.1 SYSTEM/EQUIPMENT

12.5.2 CONSUMABLES

12.5.3 OTHERS

12.6 FIBROIDS

12.6.1 SYSTEM/EQUIPMENT

12.6.2 CONSUMABLES

12.6.3 OTHERS

12.7 ADENOMYOSIS

12.7.1 SYSTEM/EQUIPMENT

12.7.2 CONSUMABLES

12.7.3 OTHERS

12.8 OTHERS

13 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP

13.1 OVERVIEW

13.2 PERI-MENOPAUSAL

13.3 PRE-MENOPAUSAL

13.4 POST-MENOPAUSAL

14 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER

14.1 OVERVIEW

14.2 HOSPITALS

14.2.1 BY TYPE

14.2.1.1 PRIVATE

14.2.1.2 PUBLIC

14.3 AMBULATORY SURGICAL CENTERS

14.4 INDEPENDENT TREATMENT CENTERS

14.5 DIAGNOSTIC IMAGING CENTERS

14.6 CLINICAL LABORATORIES

14.7 CATHERIZATION LABORATORIES

14.8 OTHERS

15 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 DIRECT TENDER

15.3 RETAIL SALES

15.4 OTHERS

16 NORTH AMERICA AND EUROPE ENDOMETRIAL ABLATION DEVICES MARKET BY REGION

16.1 NORTH AMERICA

16.1.1 U S

16.1.2 CANADA

16.1.3 MEXICO

16.2 EUROPE

16.2.1 U K

16.2.2 GERMANY

16.2.3 FRANCE

16.2.4 ITALY

16.2.5 SPAIN

16.2.6 RUSSIA

16.2.7 TURKEY

16.2.8 BELGIUM

16.2.9 NETHERLAND

16.2.10 SWITZERLAND

16.2.11 DENMARK

16.2.12 NORWAY

16.2.13 SWEDEN

16.2.14 FINLAND

16.2.15 POLAND

16.2.16 REST OF EUROPE

17 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

18 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: EUROPE

19 SWOT ANALYSIS

20 COMPANY PROFILES

20.1 HOLOGIC, INC.

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 PRODUCT PORTFOLIO

20.1.4 RECENT DEVELOPMENT

20.2 COOPERSURGICAL INC

20.2.1 COMPANY SNAPSHOT

20.2.2 PRODUCT PORTFOLIO

20.2.3 RECENT DEVELOPMENT

20.3 OLYMPUS

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENT

20.4 MINERVA SURGICAL, INC.

20.4.1 COMPANY SNAPSHOT

20.4.2 REVENUE ANALYSIS

20.4.3 PRODUCT PORTFOLIO

20.4.4 RECENT DEVELOPMENT

20.5 MEDTRONIC

20.5.1 COMPANY SNAPSHOT

20.5.2 REVENUE ANALYSIS

20.5.3 PRODUCT PORTFOLIO

20.5.4 RECENT DEVELOPMENT

20.6 CHANNEL MEDSYSTEMS INC.

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 GYNESONICS

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENT

20.8 IDOMAN-MED

20.8.1 COMPANY SNAPSHOT

20.8.2 PRODUCT PORTFOLIO

20.8.3 RECENT DEVELOPMENT

20.9 LINA MEDICAL APS.

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENT

20.1 OCON MEDICAL LTD.

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENT

20.11 RF MEDICAL CO., LTD.

20.11.1 COMPANY SNAPSHOT

20.11.2 PRODUCT PORTFOLIO

20.11.3 RECENT DEVELOPMENT

20.12 VELDANA MEDICAL

20.12.1 COMPANY SNAPSHOT

20.12.2 PRODUCT PORTFOLIO

20.12.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS

Tabellenverzeichnis

TABLE 1 COST OF ENDOMETRIAL ABLATION IN VARIOUS COUNTRY

TABLE 2 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 3 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 4 NORTH AMERICA SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 5 EUROPE SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 6 NORTH AMERICA RADIOFREQUENCY ABLATION DEVICES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 7 EUROPE RADIOFREQUENCY ABLATION DEVICES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 8 NORTH AMERICA THERMAL BALLOON ABLATION DEVICES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 9 EUROPE THERMAL BALLOON ABLATION DEVICES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 10 NORTH AMERICA CRYOABLATION DEVICES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 11 EUROPE CRYOABLATION DEVICES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 12 NORTH AMERICA SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 13 EUROPE SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 14 NORTH AMERICA CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 15 EUROPE CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 16 NORTH AMERICA ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 17 EUROPE ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 18 NORTH AMERICA ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 19 EUROPE ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 20 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 21 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 22 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 23 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 24 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 25 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 26 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 27 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 28 NORTH AMERICA NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 29 EUROPE NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 30 NORTH AMERICA RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 31 EUROPE RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 32 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 33 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 34 NORTH AMERICA ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 35 EUROPE ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 36 NORTH AMERICA MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 37 EUROPE MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 38 NORTH AMERICA DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 39 EUROPE DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 40 NORTH AMERICA POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 41 EUROPE POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 42 NORTH AMERICA FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 43 EUROPE FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 44 NORTH AMERICA ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 45 EUROPE ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 46 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 47 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 48 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 49 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 50 NORTH AMERICA HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 51 EUROPE HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 52 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 53 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 54 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 55 U.S. ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 56 U.S. SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 57 U.S. RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 58 U.S. THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 59 U.S. CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 60 U.S. SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 61 U.S. CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 62 U.S. ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 63 U.S. ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 64 U.S. ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 65 U.S. ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 66 U.S. ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 67 U.S. TOTAL NUMBER OF ENDOMETRIAL PROCEDURES, 2021-2030

TABLE 68 U.S. TOTAL NUMBER OF ENDOMETRIAL PROCEDURES, BY TECHNOLOGY, 2021-2030

TABLE 69 U.S. ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 70 U.S. NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 71 U.S. RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 72 U.S. ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 73 U.S. ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 74 U.S. MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 75 U.S. DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 76 U.S. POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 77 U.S. FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 78 U.S. ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 79 U.S. ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 80 U.S. ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 81 U.S. TOTAL NUMBER OF ENDOMETRIAL PROCEDURES, 2021-2030

TABLE 82 U.S. TOTAL NUMBER OF ENDOMETRIAL PROCEDURES, BY SITE OF CARE, 2021-2030

TABLE 83 U.S. HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 84 U.S. ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 85 CANADA ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 86 CANADA SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 87 CANADA RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 88 CANADA THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 89 CANADA CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 90 CANADA SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 91 CANADA CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 92 CANADA ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 93 CANADA ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 94 CANADA ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 95 CANADA ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 96 CANADA ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 97 CANADA ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 98 CANADA NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 99 CANADA RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 100 CANADA ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 101 CANADA ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 102 CANADA MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 103 CANADA DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 104 CANADA POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 105 CANADA FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 106 CANADA ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 107 CANADA ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 108 CANADA ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 109 CANADA HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 110 CANADA ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 111 MEXICO ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 112 MEXICO SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 113 MEXICO RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 114 MEXICO THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 115 MEXICO CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 116 MEXICO SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 117 MEXICO CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 118 MEXICO ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 119 MEXICO ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 120 MEXICO ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 121 MEXICO ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 122 MEXICO ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 123 MEXICO ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 124 MEXICO NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 125 MEXICO RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 126 MEXICO ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 127 MEXICO ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 128 MEXICO MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 129 MEXICO DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 130 MEXICO POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 131 MEXICO FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 132 MEXICO ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 133 MEXICO ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 134 MEXICO ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 135 MEXICO HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 136 MEXICO ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 137 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 138 U.K. ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 139 U.K. SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 140 U.K. RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 141 U.K. THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 142 U.K. CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 143 U.K. SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 144 U.K. CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 145 U.K. ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 146 U.K. ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 147 U.K. ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 148 U.K. ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 149 U.K. ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 150 U.K. ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 151 U.K. NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 152 U.K. RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 153 U.K. ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 154 U.K. ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 155 U.K. MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 156 U.K. DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 157 U.K. POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 158 U.K. FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 159 U.K. ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 160 U.K. ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 161 U.K. ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 162 U.K. HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 163 U.K. ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 164 GERMANY ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 165 GERMANY SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 166 GERMANY RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 167 GERMANY THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 168 GERMANY CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 169 GERMANY SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 170 GERMANY CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 171 GERMANY ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 172 GERMANY ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 173 GERMANY ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 174 GERMANY ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 175 GERMANY ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 176 GERMANY ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 177 GERMANY NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 178 GERMANY RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 179 GERMANY ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 180 GERMANY ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 181 GERMANY MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 182 GERMANY DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 183 GERMANY POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 184 GERMANY FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 185 GERMANY ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 186 GERMANY ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 187 GERMANY ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 188 GERMANY HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 189 GERMANY ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 190 FRANCE ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 191 FRANCE SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 192 FRANCE RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 193 FRANCE THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 194 FRANCE CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 195 FRANCE SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 196 FRANCE CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 197 FRANCE ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 198 FRANCE ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 199 FRANCE ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 200 FRANCE ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 201 FRANCE ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 202 FRANCE ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 203 FRANCE NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 204 FRANCE RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 205 FRANCE ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 206 FRANCE ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 207 FRANCE MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 208 FRANCE DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 209 FRANCE POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 210 FRANCE FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 211 FRANCE ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 212 FRANCE ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 213 FRANCE ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 214 FRANCE HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 215 FRANCE ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 216 ITALY ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 217 ITALY SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 218 ITALY RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 219 ITALY THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 220 ITALY CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 221 ITALY SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 222 ITALY CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 223 ITALY ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 224 ITALY ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 225 ITALY ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 226 ITALY ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 227 ITALY ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 228 ITALY ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 229 ITALY NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 230 ITALY RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 231 ITALY ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 232 ITALY ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 233 ITALY MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 234 ITALY DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 235 ITALY POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 236 ITALY FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 237 ITALY ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 238 ITALY ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 239 ITALY ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 240 ITALY HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 241 ITALY ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 242 SPAIN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 243 SPAIN SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 244 SPAIN RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 245 SPAIN THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 246 SPAIN CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 247 SPAIN SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 248 SPAIN CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 249 SPAIN ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 250 SPAIN ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 251 SPAIN ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 252 SPAIN ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 253 SPAIN ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 254 SPAIN ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 255 SPAIN NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 256 SPAIN RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 257 SPAIN ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 258 SPAIN ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 259 SPAIN MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 260 SPAIN DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 261 SPAIN POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 262 SPAIN FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 263 SPAIN ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 264 SPAIN ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 265 SPAIN ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 266 SPAIN HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 267 SPAIN ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 268 RUSSIA ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 269 RUSSIA SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 270 RUSSIA RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 271 RUSSIA THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 272 RUSSIA CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 273 RUSSIA SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 274 RUSSIA CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 275 RUSSIA ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 276 RUSSIA ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 277 RUSSIA ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 278 RUSSIA ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 279 RUSSIA ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 280 RUSSIA ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 281 RUSSIA NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 282 RUSSIA RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 283 RUSSIA ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 284 RUSSIA ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 285 RUSSIA MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 286 RUSSIA DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 287 RUSSIA POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 288 RUSSIA FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 289 RUSSIA ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 290 RUSSIA ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 291 RUSSIA ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 292 RUSSIA HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 293 RUSSIA ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 294 TURKEY ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 295 TURKEY SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 296 TURKEY RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 297 TURKEY THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 298 TURKEY CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 299 TURKEY SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 300 TURKEY CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 301 TURKEY ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 302 TURKEY ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 303 TURKEY ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 304 TURKEY ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 305 TURKEY ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 306 TURKEY ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 307 TURKEY NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 308 TURKEY RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 309 TURKEY ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 310 TURKEY ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 311 TURKEY MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 312 TURKEY DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 313 TURKEY POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 314 TURKEY FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 315 TURKEY ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 316 TURKEY ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 317 TURKEY ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 318 TURKEY HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 319 TURKEY ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 320 BELGIUM ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 321 BELGIUM SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 322 BELGIUM RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 323 BELGIUM THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 324 BELGIUM CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 325 BELGIUM SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 326 BELGIUM CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 327 BELGIUM ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 328 BELGIUM ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 329 BELGIUM ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 330 BELGIUM ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 331 BELGIUM ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 332 BELGIUM ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 333 BELGIUM NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 334 BELGIUM RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 335 BELGIUM ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 336 BELGIUM ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 337 BELGIUM MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 338 BELGIUM DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 339 BELGIUM POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 340 BELGIUM FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 341 BELGIUM ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 342 BELGIUM ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 343 BELGIUM ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 344 BELGIUM HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 345 BELGIUM ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 346 NETHERLANDS ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 347 NETHERLANDS SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 348 NETHERLANDS RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 349 NETHERLANDS THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 350 NETHERLANDS CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 351 NETHERLANDS SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 352 NETHERLANDS CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 353 NETHERLANDS ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 354 NETHERLANDS ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 355 NETHERLANDS ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 356 NETHERLANDS ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 357 NETHERLANDS ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 358 NETHERLANDS ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 359 NETHERLANDS NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 360 NETHERLANDS RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 361 NETHERLANDS ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 362 NETHERLANDS ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 363 NETHERLANDS MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 364 NETHERLANDS DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 365 NETHERLANDS POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 366 NETHERLANDS FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 367 NETHERLANDS ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 368 NETHERLANDS ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 369 NETHERLANDS ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 370 NETHERLANDS HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 371 NETHERLANDS ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 372 SWITZERLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 373 SWITZERLAND SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 374 SWITZERLAND RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 375 SWITZERLAND THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 376 SWITZERLAND CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 377 SWITZERLAND SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 378 SWITZERLAND CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 379 SWITZERLAND ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 380 SWITZERLAND ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 381 SWITZERLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 382 SWITZERLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 383 SWITZERLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 384 SWITZERLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 385 SWITZERLAND NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 386 SWITZERLAND RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 387 SWITZERLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 388 SWITZERLAND ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 389 SWITZERLAND MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 390 SWITZERLAND DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 391 SWITZERLAND POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 392 SWITZERLAND FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 393 SWITZERLAND ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 394 SWITZERLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 395 SWITZERLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 396 SWITZERLAND HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 397 SWITZERLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 398 DENMARK ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 399 DENMARK SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 400 DENMARK RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 401 DENMARK THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 402 DENMARK CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 403 DENMARK SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 404 DENMARK CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 405 DENMARK ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 406 DENMARK ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 407 DENMARK ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 408 DENMARK ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 409 DENMARK ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 410 DENMARK ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 411 DENMARK NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 412 DENMARK RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 413 DENMARK ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 414 DENMARK ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 415 DENMARK MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 416 DENMARK DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 417 DENMARK POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 418 DENMARK FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 419 DENMARK ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 420 DENMARK ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 421 DENMARK ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 422 DENMARK HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 423 DENMARK ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 424 NORWAY ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 425 NORWAY SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 426 NORWAY RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 427 NORWAY THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 428 NORWAY CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 429 NORWAY SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 430 NORWAY CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 431 NORWAY ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 432 NORWAY ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 433 NORWAY ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 434 NORWAY ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 435 NORWAY ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 436 NORWAY ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 437 NORWAY NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 438 NORWAY RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 439 NORWAY ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 440 NORWAY ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 441 NORWAY MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 442 NORWAY DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 443 NORWAY POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 444 NORWAY FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 445 NORWAY ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 446 NORWAY ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 447 NORWAY ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 448 NORWAY HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 449 NORWAY ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 450 SWEDEN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 451 SWEDEN SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 452 SWEDEN RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 453 SWEDEN THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 454 SWEDEN CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 455 SWEDEN SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 456 SWEDEN CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 457 SWEDEN ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 458 SWEDEN ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 459 SWEDEN ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 460 SWEDEN ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 461 SWEDEN ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 462 SWEDEN ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 463 SWEDEN NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 464 SWEDEN RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 465 SWEDEN ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 466 SWEDEN ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 467 SWEDEN MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 468 SWEDEN DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 469 SWEDEN POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 470 SWEDEN FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 471 SWEDEN ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 472 SWEDEN ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 473 SWEDEN ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 474 SWEDEN HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 475 SWEDEN ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 476 FINLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 477 FINLAND SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 478 FINLAND RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 479 FINLAND THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 480 FINLAND CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 481 FINLAND SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 482 FINLAND CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 483 FINLAND ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 484 FINLAND ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 485 FINLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 486 FINLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 487 FINLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 488 FINLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 489 FINLAND NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 490 FINLAND RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 491 FINLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 492 FINLAND ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 493 FINLAND MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 494 FINLAND DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 495 FINLAND POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 496 FINLAND FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 497 FINLAND ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 498 FINLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 499 FINLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 500 FINLAND HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 501 FINLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 502 POLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 503 POLAND SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 504 POLAND RADIOFREQUENCY ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 505 POLAND THERMAL BALLOON ABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 506 POLAND CRYOABLATION DEVICE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 507 POLAND SYSTEM/EQUIPMENT IN ENDOMETRIAL ABLATION DEVICES MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 508 POLAND CONSUMABLES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 509 POLAND ENDOMETRIAL ABLATION PROBES IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 510 POLAND ELECTRODE IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 511 POLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY, 2021-2030 (USD THOUSAND)

TABLE 512 POLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE, 2021-2030 (USD THOUSAND)

TABLE 513 POLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 514 POLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE, 2021-2030 (USD THOUSAND)

TABLE 515 POLAND NON-RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 516 POLAND RESECTOSCOPIC IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 517 POLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 518 POLAND ABNORMAL UTERINE BLEEDING (AUB) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 519 POLAND MENORRHAGIA (HEAVY MENSTRUAL BLEEDING) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 520 POLAND DYSMENORRHEA (PAINFUL MENSTRUATION) IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 521 POLAND POLYPS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 522 POLAND FIBROIDS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 523 POLAND ADENOMYOSIS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 524 POLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)

TABLE 525 POLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 526 POLAND HOSPITALS IN ENDOMETRIAL ABLATION DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 527 POLAND ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 528 REST OF EUROPE ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

Abbildungsverzeichnis

FIGURE 1 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 6 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 7 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 12 NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: SEGMENTATION

FIGURE 13 INCREASING INCIDENCE OF MENSTRUAL DISORDERS IS EXPECTED TO DRIVE THE NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET IN THE FORECAST PERIOD

FIGURE 14 RISING PREVALENCE OF ENDOMETRIAL CANCER IS EXPECTED TO DRIVE THE NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET IN THE FORECAST PERIOD

FIGURE 15 SYSTEM/EQUIPMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET IN 2023 & 2030

FIGURE 16 SYSTEM/EQUIPMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ENDOMETRIAL ABLATION DEVICES MARKET IN 2023 & 2030

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA & EUROPE ENDOMETRIAL ABLATION DEVICES MARKET

FIGURE 18 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: BY PRODUCT TYPE, 2022

FIGURE 19 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: BY PRODUCT TYPE, 2022

FIGURE 20 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: BY PORTABILITY, 2022

FIGURE 21 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: BY PORTABILITY, 2022

FIGURE 22 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: BY SITE, 2022

FIGURE 23 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: BY SITE, 2022

FIGURE 24 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: BY TECHNOLOGY, 2022

FIGURE 25 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: BY TECHNOLOGY, 2022

FIGURE 26 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: BY TECHNIQUE, 2022

FIGURE 27 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: BY TECHNIQUE, 2022

FIGURE 28 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: BY APPLICATION, 2022

FIGURE 29 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: BY APPLICATION, 2022

FIGURE 30 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: BY AGE GROUP, 2022

FIGURE 31 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: BY AGE GROUP, 2022

FIGURE 32 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: BY END USER, 2022

FIGURE 33 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: BY END USER, 2022

FIGURE 34 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 35 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 36 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: SNAPSHOT (2022)

FIGURE 37 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: SNAPSHOT (2022)

FIGURE 38 NORTH AMERICA ENDOMETRIAL ABLATION DEVICES MARKET: COMPANY SHARE 2022 (%)

FIGURE 39 EUROPE ENDOMETRIAL ABLATION DEVICES MARKET: COMPANY SHARE 2022 (%)

Detaillierte Informationen anzeigen Right Arrow

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The North America and Europe Endometrial Ablation Devices Market will be worth USD 471,904.07 thousand & USD 320,682.85 thousand respectively by 2030.
The North America and Europe Endometrial Ablation Devices Market growth rate is 7.6% and 7.3% respectively during the forecast period by 2030.
Increasing Incidence of Menstrual Disorders & growing pool of patients seeking treatment are the growth drivers of the North America and Europe Endometrial Ablation Devices Market.
The product type, portability, site, technology, technique, application, age group, end-user and distribution channel are the factors on which the North America and Europe Endometrial Ablation Devices Market research is based.
Hologic, Inc., a world leader in women's healthcare, introduces the NovaSure V5 device, a global endometrial ablation (GEA) device, at the American Association of Gynecologic Laparoscopy (AAGL) 50th World Congress & CooperSurgical Inc. announced the acquisition of California-based AEGEA Medical and its FDA-approved Mara water vapor ablation system are the latest developments in the North America and Europe Endometrial Ablation Devices Market.